Opulence Capital Management

Nano Cures announced $90M pre-IPO funding round

Nano Cures, a clinical stage biotechnology and infectious disease immunity platform company, today announced a $90M pre-IPO funding round. The investment will be led by a $20M commitment from Opulence...

Nano Cures announced $90M pre-IPO funding round

Bahrain offers 48% cost advantage for financial firm

BlueFive Capital raises $2 billion GCC PE fund

Mobile game studio Million Victories raises $40 million

Ruya Partners extends $15M credit facility to TruKKer

XPANCEO raises $250 million at $1.35 billion valuation

Nano Cures announced $90M pre-IPO funding round

Sign In

Lost Password